Brain CT and MRI for early stage lung cancer patients are not routinely recommended.
Many patients newly diagnosed with early non-small cell lung cancer (NSCLC) are undergoing brain imaging despite Choosing Wisely recommendations to the contrary, according to a study published in Chest.
Researchers sought to determine how brain imaging was used among asymptomatic patients with stage IA NSCLC, who were part of the National Lung Screening Trial.
The researchers identified 643 patients for the study. They had all received CT or MRIswithin 60 days after diagnosis, but before definitive surgical staging. The results showed that 77 (12%) of these patients had at least one brain imaging study, but of seven patients (1.1%) who were upstaged to stage IV, only two underwent brain imaging and neither had documentation of brain metastasis.
According to the findings, brain imaging frequency varied from 0% to 80%, depending on the enrollment center. “All patients who underwent brain imaging subsequently underwent surgery with curative intent, suggesting strongly that imaging revealed no evidence of intracranial metastases,” the authors wrote. Primary tumor size of less than 20 mm and being aged 65 to 69 were independently associated with greater use of brain imaging.[[{"type":"media","view_mode":"media_crop","fid":"48178","attributes":{"alt":"brain imaging","class":"media-image media-image-right","id":"media_crop_3770433627797","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5737","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 113px; width: 169px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©Andrey Burmakin/Shutterstock.com","typeof":"foaf:Image"}}]]
The researchers concluded that one in eight patients enrolled in the National Lung Screening Trial underwent brain imaging, but no patient was found to have intracranial metastases. “Wide variation in use between centers suggests either lack of awareness or disagreement about this Choosing Wisely recommendation,” they wrote.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.
What a Prospective CT Study Reveals About Adjunctive AI for Triage of Intracranial Hemorrhages
September 4th 2024Adjunctive AI showed no difference in accuracy than unassisted radiologists for intracranial hemorrhage (ICH) detection and had a slightly longer mean report turnaround time for ICH-positive cases, according to newly published prospective research.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).